Usefulness of monitoring circulating tumor cells as a therapeutic biomarker in melanoma with BRAF mutation

BACKGROUND: While molecularly targeted therapies and immune checkpoint inhibitors have improved the prognosis of advanced melanoma, biomarkers are required to monitor drug responses. Circulating tumor cells (CTCs) are released from primary and/or metastatic tumors into the peripheral blood. We exami...

Full description

Saved in:
Bibliographic Details
Published in:BMC Cancer
Main Authors: Kiniwa, Yukiko, Nakamura, Kenta, Mikoshiba, Asuka, Ashida, Atsuko, Akiyama, Yasuyuki, Morimoto, Atsushi, Okuyama, Ryuhei
Format: Artigo
Language:Inglês
Published: BioMed Central 2021
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7968258/
https://ncbi.nlm.nih.gov/pubmed/33731038
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-021-08016-y
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items